Literature DB >> 1520784

Septic arthritis and bacteremia due to Mycoplasma resistant to antimicrobial therapy in a patient with systemic lupus erythematosus.

W Clough1, G H Cassell, L B Duffy, R Z Rinaldi, R Bluestone, M A Morgan, R D Meyer.   

Abstract

We report a case of septic arthritis caused by Mycoplasma hominis in a patient with systemic lupus erythematosus. The infection started as monarthritis but spread to at least four joints despite apparently suitable therapy with various antimicrobial agents, including doxycycline, clindamycin, and ciprofloxacin; subsequent bacteremia was documented. Control was ultimately achieved with use of the experimental fluoroquinolone temafloxacin in combination with doxycycline administration, arthroscopic drainage of a persistently infected joint, several intravenous infusions of immunoglobulins (which led to increases in levels of antibodies specific to M. hominis), and discontinuation of corticosteroid therapy. Antimicrobial susceptibility testing of various mycoplasmal isolates showed the presence of the tetM gene, disparity between susceptibility to tetracycline and doxycycline, and increasing resistance to most antimicrobial agents used (including to fluoroquinolones before clinical use), although the patient ultimately had a favorable clinical response to treatment with combined modalities.

Entities:  

Mesh:

Year:  1992        PMID: 1520784     DOI: 10.1093/clind/15.3.402

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Mycoplasma hominis osteitis in an immunocompetent man.

Authors:  F Méchaï; G Le Moal; S Duchêne; C Burucoa; C Godet; M Freslon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-11       Impact factor: 3.267

2.  An enemy in shadows-Mycoplasma hominis septic arthritis and iliopsoas abscess: Case report and review of the literature.

Authors:  Gawahir A Ali; Wael Goravey; Abdulrahman Hamad; Emad B Ibrahim; Mohamed R Hasan; Muna Al Maslamani; Hussam Al Soub
Journal:  IDCases       Date:  2021-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.